Literature DB >> 11122949

The genetics of Alzheimer's disease.

G D Schellenberg1, I D'Souza, P Poorkaj.   

Abstract

Alzheimer's disease (AD) is a genetically complex disorder. Mutations in the amyloid precursor protein and presenilin 1 (PS1) genes are fully penetrant and cause early-onset AD. Mutations in presenilin 2, a PS1 homologue, cause partially penetrant autosomal dominant AD with onset age beginning at 40 years and extending past 75 years. A fourth gene, apolipoprotein E (ApoE) is a risk-factor for late-onset AD. Over 40 genes have been tested as AD candidate genes, yet none has been clearly established as an AD risk factor. Linkage studies have implicated a number of chromosome regions as possible sites for late-onset AD loci with the strongest evidence being for chromosome 12. Candidate genes in this region include alpha2-macroglobulin (A2M) and low-density lipoprotein receptor-related gene (LRP), although neither has been clearly established as an AD gene. Identification of additional late-onset genes will require larger samples, more sophisticated analysis methods, and large-scale positional cloning efforts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122949     DOI: 10.1007/s11920-000-0061-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  52 in total

1.  Further evidence linking late-onset Alzheimer disease with chromosome 12.

Authors:  W K Scott; J M Grubber; S M Abou-Donia; T D Church; A M Saunders; A D Roses; M A Pericak-Vance; P M Conneally; G W Small; J L Haines
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

2.  Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK.

Authors:  D J Dow; N Lindsey; N J Cairns; C Brayne; D Robinson; F A Huppert; E S Paykel; J Xuereb; G Wilcock; J L Whittaker; D C Rubinsztein
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

3.  Association at LRP gene locus with sporadic late-onset Alzheimer's disease.

Authors:  J C Lambert; F Wavrant-De Vrièze; P Amouyel; M C Chartier-Harlin
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

4.  No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample.

Authors:  D Fallin; A Kundtz; T Town; A C Gauntlett; R Duara; W Barker; F Crawford; M Mullan
Journal:  Neurosci Lett       Date:  1997-09-19       Impact factor: 3.046

5.  Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease.

Authors:  V Alvarez; R Alvarez; C H Lahoz; C Martínez; J Peña; L M Guisasola; J Salas-Puig; G Morís; D Uría; B B Menes; R Ribacoba; J A Vidal; J M Sánchez; E Coto
Journal:  Biochem Biophys Res Commun       Date:  1999-10-14       Impact factor: 3.575

6.  A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

Authors:  M J Bullido; M J Artiga; M Recuero; I Sastre; M A García; J Aldudo; C Lendon; S W Han; J C Morris; A Frank; J Vázquez; A Goate; F Valdivieso
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

7.  The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease.

Authors:  U Beffert; C Arguin; J Poirier
Journal:  Neurosci Lett       Date:  1999-01-04       Impact factor: 3.046

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.

Authors:  A Liao; R M Nitsch; S M Greenberg; U Finckh; D Blacker; M Albert; G W Rebeck; T Gomez-Isla; A Clatworthy; G Binetti; C Hock; T Mueller-Thomsen; U Mann; K Zuchowski; U Beisiegel; H Staehelin; J H Growdon; R E Tanzi; B T Hyman
Journal:  Hum Mol Genet       Date:  1998-11       Impact factor: 6.150

10.  No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.

Authors:  J L Haines; M L Pritchard; A M Saunders; J M Schildkraut; J H Growdon; P C Gaskell; L A Farrer; S A Auerbach; J F Gusella; P A Locke; B L Rosi; L Yamaoka; G W Small; P M Conneally; A D Roses; M A Pericak-Vance
Journal:  Genomics       Date:  1996-04-01       Impact factor: 5.736

View more
  19 in total

Review 1.  Identifying genes and genetic variation underlying human diseases and complex phenotypes via recombination mapping.

Authors:  Ulrich Broeckel; Nicholas J Schork
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

2.  A genome-wide linkage analysis of dementia in the Amish.

Authors:  Daniel W Hahs; Jacob L McCauley; Amy E Crunk; Lynne L McFarland; Perry C Gaskell; Lan Jiang; Susan H Slifer; Jeffery M Vance; William K Scott; Kathleen A Welsh-Bohmer; Stephanie R Johnson; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

3.  Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

Authors:  Chang-En Yu; Howard Seltman; Elaine R Peskind; Nichole Galloway; Peter X Zhou; Elisabeth Rosenthal; Ellen M Wijsman; Debby W Tsuang; Bernie Devlin; Gerard D Schellenberg
Journal:  Genomics       Date:  2007-04-16       Impact factor: 5.736

4.  Biparietal variant of Alzheimer's disease: a rare presentation of a common disease.

Authors:  Inês B Marques; Miguel Tábuas-Pereira; Miguel Milheiro; Isabel Santana
Journal:  BMJ Case Rep       Date:  2015-01-05

5.  Aging and neurogenesis, a lesion from Alzheimer's disease.

Authors:  Philippe Taupin
Journal:  Aging Dis       Date:  2010-04-28       Impact factor: 6.745

6.  Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

Authors:  Nilüfer Ertekin-Taner; James Ronald; Hideaki Asahara; Linda Younkin; Maria Hella; Shushant Jain; Eugene Gnida; Samuel Younkin; Daniel Fadale; Yasumasa Ohyagi; Adam Singleton; Leah Scanlin; Mariza de Andrade; Ronald Petersen; Neill Graff-Radford; Michael Hutton; Steven Younkin
Journal:  Hum Mol Genet       Date:  2003-10-14       Impact factor: 6.150

7.  Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture.

Authors:  Nicholas J Hargus; Stanley A Thayer
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

Review 8.  Chasing genes in Alzheimer's and Parkinson's disease.

Authors:  Aida M Bertoli-Avella; Ben A Oostra; Peter Heutink
Journal:  Hum Genet       Date:  2004-03-04       Impact factor: 4.132

9.  Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.

Authors:  Lynn M Bekris; Steven P Millard; Nichole M Galloway; Simona Vuletic; John J Albers; Ge Li; Douglas R Galasko; Charles DeCarli; Martin R Farlow; Chris M Clark; Joseph F Quinn; Jeffrey A Kaye; Gerard D Schellenberg; Debby Tsuang; Elaine R Peskind; Chang-En Yu
Journal:  J Alzheimers Dis       Date:  2008-04       Impact factor: 4.472

10.  Otitis media: a genome-wide linkage scan with evidence of susceptibility loci within the 17q12 and 10q22.3 regions.

Authors:  Margaretha L Casselbrant; Ellen M Mandel; Jeesun Jung; Robert E Ferrell; Kathleen Tekely; Jin P Szatkiewicz; Amrita Ray; Daniel E Weeks
Journal:  BMC Med Genet       Date:  2009-09-03       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.